XERS - Xeris Pharmaceuticals Inc. (XERS) CEO Paul Edick on Q4 2020 Results - Earnings Call Transcript

Xeris Pharmaceuticals, Inc. (XERS) Q4 2020 Earnings Conference Call March 09, 2021 08:30 AM ET Company Participants Allison Wey - Senior Vice President of Investor Relations Paul Edick - Chairman & Chief Executive Officer Barry Deutsch - Chief Financial Officer Conference Call Participants David Amsellem - Piper Sandler Ami Fadia - SVB Leerink Randall Stanicky - RBC Difei Yang - Mizuho Group Presentation Operator Ladies and gentlemen, thank you for standing by. And welcome to today's Xeris Pharmaceuticals Fourth Quarter Final Results Conference Call. At this time, all participants are in a listen-only mode. After the speakers' remarks, there will be a question-and-answer session. [Operator Instructions] I would now like to hand the conference over to your speaker, Allison Wey, Senior Vice President of Investor Relations. Please, go ahead. Allison Wey Thank you, Mae. Good morning and welcome to Xeris' Pharmaceuticals fourth quarter and full year 2020 financial results and

For further details see:

Xeris Pharmaceuticals, Inc. (XERS) CEO Paul Edick on Q4 2020 Results - Earnings Call Transcript